Laboratory Markers Helpful in Diagnosing Kawasaki Disease in Febrile Infant: Role of Age-adjusted Z-values of Blood Cells.
作者信息
Yoo Gyeonghee
机构信息
Department of Pediatrics, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
出版信息
Korean Circ J. 2019 Aug;49(8):766-768. doi: 10.4070/kcj.2019.0133. Epub 2019 May 15.
Abstract
摘要
相似文献
1
Laboratory Markers Helpful in Diagnosing Kawasaki Disease in Febrile Infant: Role of Age-adjusted Z-values of Blood Cells.
Korean Circ J. 2019 Aug;49(8):766-768. doi: 10.4070/kcj.2019.0133. Epub 2019 May 15.
2
Significance of Differential Characteristics in Infantile Kawasaki Disease.
Korean Circ J. 2019 Aug;49(8):755-765. doi: 10.4070/kcj.2018.0434. Epub 2019 Apr 5.
3
Coronary artery dimensions in febrile children without Kawasaki disease.
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):239-44. doi: 10.1161/CIRCIMAGING.112.000159. Epub 2013 Jan 28.
4
Febrile convulsion during the acute phase of Kawasaki disease.
Pediatr Int. 2004 Feb;46(1):31-2. doi: 10.1111/j.1442-200X.2004.01850.x.
5
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Lancet. 2014 May 17;383(9930):1731-8. doi: 10.1016/S0140-6736(13)62298-9. Epub 2014 Feb 24.
6
Initial characteristics of Kawasaki disease with cerebrospinal fluid pleocytosis in febrile infants.
Pediatr Neurol. 2012 Oct;47(4):259-62. doi: 10.1016/j.pediatrneurol.2012.06.011.
7
Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease.
Cardiology. 2002;97(4):180-2. doi: 10.1159/000063118.
8
Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
Dis Markers. 2017;2017:6263121. doi: 10.1155/2017/6263121. Epub 2017 Nov 22.
9
Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.
JAMA Pediatr. 2018 Dec 1;172(12):e183310. doi: 10.1001/jamapediatrics.2018.3310. Epub 2018 Dec 3.
10
Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
J Korean Med Sci. 2004 Dec;19(6):800-4. doi: 10.3346/jkms.2004.19.6.800.
本文引用的文献
1
Significance of Differential Characteristics in Infantile Kawasaki Disease.
Korean Circ J. 2019 Aug;49(8):755-765. doi: 10.4070/kcj.2018.0434. Epub 2019 Apr 5.
2
Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease.
Front Pediatr. 2019 Mar 19;7:81. doi: 10.3389/fped.2019.00081. eCollection 2019.
3
Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.
Korean Circ J. 2018 Apr;48(4):287-295. doi: 10.4070/kcj.2017.0342.
4
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
5
Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Pediatr Cardiol. 2017 Feb;38(2):375-380. doi: 10.1007/s00246-016-1525-1. Epub 2016 Nov 23.
6
Early Detection of Kawasaki Disease in Infants.
Korean Circ J. 2015 Nov;45(6):510-5. doi: 10.4070/kcj.2015.45.6.510. Epub 2015 Nov 25.
7
Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.
Eur J Pediatr. 2013 Mar;172(3):343-9. doi: 10.1007/s00431-012-1891-5. Epub 2012 Nov 16.
8
Evolution of laboratory values in patients with Kawasaki disease.
Pediatr Infect Dis J. 2011 Dec;30(12):1022-6. doi: 10.1097/INF.0b013e31822d4f56.
Zotero 插件